Inflammasomes as therapeutic targets in human diseases

Y Li, H Huang, B Liu, Y Zhang, X Pan, XY Yu… - Signal transduction and …, 2021 - nature.com
Inflammasomes are protein complexes of the innate immune system that initiate
inflammation in response to either exogenous pathogens or endogenous danger signals …

Diverging inflammasome signals in tumorigenesis and potential targeting

R Karki, TD Kanneganti - Nature Reviews Cancer, 2019 - nature.com
Inflammasomes are molecular platforms that assemble upon sensing various intracellular
stimuli. Inflammasome assembly leads to activation of caspase 1, thereby promoting the …

NLRP3 inflammasome and inflammatory bowel disease

Y Zhen, H Zhang - Frontiers in immunology, 2019 - frontiersin.org
NLRP3 inflammasome can be widely found in epithelial cells and immune cells. The NOD-
like receptors (NLRs) family member NLRP3 contains a central nucleotide-binding and …

The PANoptosome: a deadly protein complex driving pyroptosis, apoptosis, and necroptosis (PANoptosis)

P Samir, RKS Malireddi, TD Kanneganti - Frontiers in cellular and …, 2020 - frontiersin.org
Programmed cell death is regulated by evolutionarily conserved pathways that play critical
roles in development and the immune response. A newly recognized pathway for …

Advances in mechanism and regulation of PANoptosis: Prospects in disease treatment

P Zhu, ZR Ke, JX Chen, SJ Li, TL Ma… - Frontiers in …, 2023 - frontiersin.org
PANoptosis, a new research hotspot at the moment, is a cell death pattern in which
pyroptosis, apoptosis, and necroptosis all occur in the same cell population. In essence …

[HTML][HTML] TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants–past, present and future

LM Sedger, MF McDermott - Cytokine & growth factor reviews, 2014 - Elsevier
Abstract Tumor Necrosis Factor (TNF), initially known for its tumor cytotoxicity, is a potent
mediator of inflammation, as well as many normal physiological functions in homeostasis …

[HTML][HTML] Intestinal barrier in inflammatory bowel disease

L Antoni, S Nuding, J Wehkamp… - World journal of …, 2014 - ncbi.nlm.nih.gov
A complex mucosal barrier protects as the first line of defense the surface of the healthy
intestinal tract from adhesion and invasion by luminal microorganisms. In this review, we …

NLRP3: a promising therapeutic target for autoimmune diseases

HH Shen, YX Yang, X Meng, XY Luo, XM Li… - Autoimmunity …, 2018 - Elsevier
NLRP3, a member of nucleotide-binding domain-(NOD) like receptor family, can be found in
large varieties of immune and non-immune cells. Upon activation, the NLRP3, apoptosis …

NLRP 3 inflammasome expression and activation in human atherosclerosis

G Paramel Varghese, L Folkersen… - Journal of the …, 2016 - Am Heart Assoc
Background The NLR family, pyrin domain containing 3 (NLRP 3) inflammasome is an
interleukin (IL)‐1β and IL‐18 cytokine processing complex that is activated in inflammatory …

Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome

C Bauer, P Duewell, C Mayer, HA Lehr, KA Fitzgerald… - Gut, 2010 - gut.bmj.com
Background The proinflammatory cytokines interleukin 1β (IL-1β) and IL-18 are central
players in the pathogenesis of inflammatory bowel disease (IBD). In response to a variety of …